UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease

Nature reviews. Gastroenterology & hepatology, 2022-06, Vol.19 (6), p.351-366

2022

Volltextzugriff (PDF)

Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases

Clinical gastroenterology and hepatology, 2020-05, Vol.18 (6), p.1381-1392

2020

Volltextzugriff (PDF)

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

Nature genetics, 2007-05, Vol.39 (5), p.596-604

2007

Volltextzugriff (PDF)

Cannabis use amongst patients with inflammatory bowel disease

European journal of gastroenterology & hepatology, 2011-10, Vol.23 (10), p.891-896

2011

Volltextzugriff (PDF)

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

Nature reviews. Gastroenterology & hepatology, 2023-07, Vol.20 (7), p.433-446

2023

Volltextzugriff (PDF)

Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's disease

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e401-e406

2021

Volltextzugriff (PDF)

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

Nature genetics, 2009-01, Vol.41 (1), p.71-76

2009

Volltextzugriff (PDF)

Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk

Gastroenterology (New York, N.Y. 1943), 2021-11, Vol.161 (5), p.1540-1551

2021

Volltextzugriff (PDF)

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1139-1148

2013

Volltextzugriff (PDF)

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Gut, 2023-08, Vol.72 (8), p.1462-1471

2023

Volltextzugriff (PDF)

Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease

Nature genetics, 2008-09, Vol.40 (9), p.1107-1112

2008

Volltextzugriff (PDF)

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

Gut, 2013-03, Vol.62 (3), p.387-394

2013

Volltextzugriff (PDF)

Future directions in inflammatory bowel disease management

Journal of Crohn's and colitis, 2014-08, Vol.8 (8), p.726-734

2014

Volltextzugriff (PDF)

Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring System

Arthritis care & research (2010), 2018-05, Vol.70 (5), p.807-810

2018

Volltextzugriff (PDF)

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2022-10, Vol.163 (4), p.950-964

2022

Volltextzugriff (PDF)

Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study

Inflammatory bowel diseases, 2016-06, Vol.22 (6), p.1412-1417

2016

Volltextzugriff (PDF)

Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease

Alimentary pharmacology & therapeutics, 2024-08, Vol.60 (3), p.310-326

2024

Volltextzugriff (PDF)

The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease

Journal of Crohn's and colitis, 2018-04, Vol.12 (4), p.458-464

2018

Volltextzugriff (PDF)

The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population

Frontiers in immunology, 2023-08, Vol.14, p.1161901-1161901

2023

Volltextzugriff (PDF)

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci

PLoS genetics, 2012-03, Vol.8 (3), p.e1002559-e1002559

2012

Volltextzugriff (PDF)

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

BMC medical genetics, 2020-10, Vol.21 (1), p.1-204, Article 204

2020

Volltextzugriff (PDF)

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Journal of gastroenterology and hepatology, 2021-10, Vol.36 (10), p.2803-2812

2021

Volltextzugriff (PDF)

Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response

Arthritis & rheumatology (Hoboken, N.J.), 2017-05, Vol.69 (5), p.1009-1015

2017

Volltextzugriff (PDF)

Serum Analyte Profiles Associated With Crohn’s Disease and Disease Location

Inflammatory bowel diseases, 2022-01, Vol.28 (1), p.9-20

2022

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

ThemaCrohn's Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease

Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

Cannabis use amongst patients with inflammatory bowel disease

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's disease

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk

Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients

Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis

Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease

Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease

Future directions in inflammatory bowel disease management

Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring System

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study

Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease

The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease

The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population

A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci

Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects

Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis

Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response

Serum Analyte Profiles Associated With Crohn’s Disease and Disease Location

Aktive Filter

Suchergebnisse filtern